Literature DB >> 27621336

Diseases due to unhealthy environments: an updated estimate of the global burden of disease attributable to environmental determinants of health.

A Prüss-Ustün1, J Wolf2,3,4, C Corvalán5, T Neville1, R Bos1, M Neira1.   

Abstract

Background: The update of the global burden of disease attributable to the environment is presented. The study focuses on modifiable risks to show the potential health impact from environmental interventions.
Methods: Systematic literature reviews on 133 diseases and injuries were performed. Comparative risk assessments were complemented by more limited epidemiological estimates, expert opinion and information on disease transmission pathways. Population attributable fractions were used to calculate global deaths and global disease burden from environmental risks.
Results: Twenty-three percent (95% CI: 13-34%) of global deaths and 22% (95% CI: 13-32%) of global disability adjusted life years (DALYs) were attributable to environmental risks in 2012. Sixty-eight percent of deaths and 56% of DALYs could be estimated with comparative risk assessment methods. The global disease burden attributable to the environment is now dominated by noncommunicable diseases. Susceptible ages are children under five and adults between 50 and 75 years. Country level data are presented. Conclusions: Nearly a quarter of global disease burden could be prevented by reducing environmental risks. This analysis confirms that eliminating hazards and reducing environmental risks will greatly benefit our health, will contribute to attaining the recently agreed Sustainable Development Goals and will systematically require intersectoral collaboration to be successful. © The World Health Organization [2016]. Published by Oxford University Press on behalf of The Faculty of Public Health.

Entities:  

Keywords:  environment; morbidity and mortality; public health

Mesh:

Year:  2017        PMID: 27621336      PMCID: PMC5939845          DOI: 10.1093/pubmed/fdw085

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


Introduction

Attribution of the burden of disease to environmental risks highlights the importance of environmental protection for people's health and can inform priority setting for targeted management of environmental determinants. Ten years ago the global burden of disease attributable to the environment was estimated for the first time in a comprehensive, systematic and transparent way.[1] The study concluded that as much as 24% of disability adjusted life years (DALYs) and 23% of deaths were due to modifiable environmental risks.[1] The health impacts of specific risk factors have traditionally been assessed separately.[2,3] A comprehensive account of the consequences of unhealthy environments that are modifiable outlines the full potential of disease prevention that can be achieved by reconsidering the way we shape our environment. Since the last assessment 10 years ago,[1] considerable more evidence has become available which justifies an updated assessment. We present here the methods and results of a new study which updates the previous analysis, by compiling the most recent synthesized and other key evidence on each disease and injury and their links to the environment.[4] We present environmental burden of disease both in terms of environment-attributable mortality and DALYs, a weighted measure of death and disability. The aim of the study is to quantify the links between disease or injury and environmental risks using CRAs and alternative methods and to derive an estimate of the environmental disease burden, overall, by region and country. For policy relevance, we deliberately focus on those risks which could be prevented or reduced by feasible interventions which modify the environment. The assessment was completed by a review of effective interventions for each of the investigated diseases.

Methods

Defining the environment in the context of public health

Environmental health has been defined as that part of public health that addresses all the physical, chemical and biological determinants of health external to a person, and all the related factors impacting behaviours.[5] Included under environment for the purpose of this study are exposure to pollution and chemicals (e.g. air, water, soil, products), physical exposures (e.g. noise, radiation), the built environment (e.g. housing, land-use, infrastructure), other anthropogenic changes (e.g. climate change, vector breeding places), related behaviours and the work environment. Excluded are life style factors and behaviours which have no or only minor relations with the physical environment such as diet, tobacco or alcohol consumption, environments which cannot reasonably be modified (e.g. wetlands, pollen), or social conditions and unemployment. These risks are further detailed in Supplementary File (A1). The focus is placed on disease which can be prevented, either with almost immediate effect, or with longer term transformations.

Systematic literature review

For each of the 133 disease and injury groups,[2] we searched the literature systematically using Pubmed and Google Scholar for population health impacts from environmental risks and effects of interventions addressing those risks. The search strategy included a range of different MeSH (Medical Subject Headings) terms and keywords on each of the diseases or injuries, combined with terms for ‘environment’, ‘occupation’, relevant environmental risks and any of the occupational groups at risk, starting from the year 2004 until 2014. Older literature was taken from the earlier study[1] and major projects of risk assessments were reviewed. Furthermore, the literature and data repositories were screened for documented and publicly available data and information on population health impacts, effects of interventions, exposure-response relationships, transmission pathways and causality. Global estimates of population impacts from environmental risks were completed with national or regional estimates, results of systematic reviews and meta-analyses on disease reduction from interventions or on environmental determinants; and finally by individual studies on interventions and environmental determinants. The focus on evidence of interventions underlines risk reductions that are already feasible, whereas other risk reductions may not yet be feasible or performed at large scale. Only risk factors with an established link of causality to health were further considered.

Estimation of the population attributable fraction

The population attributable fraction (PAF) of a risk factor is the proportional reduction in population death or disease that would occur if exposure to this factor was removed or reduced to an achievable, alternative (or counterfactual) exposure distribution.[6] To calculate the PAF of a risk factor to a disease, the following information is needed: (i) the exposure distribution to the risk factor within the population of interest, (ii) the relative risk (RR) linking each level of exposure to the specific disease or injury, and (iii) an alternative (counterfactual) exposure distribution to which environmental risks could be reduced. The counterfactual exposure distributions were based either on evidence from interventions, removal of pathways which have been eliminated elsewhere, or exposures achieved in some populations or areas. According to the results of the systematic literature review (see above), four different approaches were used to estimate the fraction of diseases attributable to environmental risks in the following order of priority: (i) CRAs, which generally provide estimates based on the highest levels of evidence and most comprehensive data,[7-10] (ii) estimates based on more limited exposure information and/or exposure-risk relationships, (iii) diseases with a transmission pathway dependent on specific modifiable environmental conditions were fully attributed to the environment (such as intestinal nematode infections which require contamination of the environment by human excreta), and (iv) expert surveys.

Estimation of burden of disease attributable to the environment

In priority, we used systematic global estimates of population impacts from environmental risks (CRA type of assessments).[2,11-13] These assessments are systematic evaluations of changes in population health resulting from modifying the population distribution of exposure from the current situation as compared to an alternative exposure, in combination with corresponding exposure-risk relationships. In these assessments, exposure is assessed for country populations as much as possible, the extrapolability of exposure-response relationship screened. CRA type of assessments are the method of choice and represent the highest level of evidence for environmental health conditions with a clear, established link between exposure and health outcome, such as exposure to air pollution or inadequate water and sanitation, chemicals or radiation. However, often available data is too limited to perform CRA type of assessments such as for insect vectors of diseases or rodent reservoirs of zoonoses which are more difficult to measure or which show a level of variation that is hard to translate in a disease burden, and alternative methods as specified below needed to be used. Information on estimating disease burden from a combination of different risks is given in Supplementary File (A2). When sufficient exposure distributions, or exposure-risk estimates or other important information was missing to perform CRA type of assessments, estimates based on more limited epidemiological data were performed, such as for HIV/AIDS, Hepatitis B, other sexually transmitted diseases, suicide and underweight. Additional information can be found in the full WHO report on this work.[4] For several diseases, approximate epidemiological estimations were also used to support expert opinion (e.g. unintentional injuries from fires). Certain infectious diseases are solely transmitted through pathways which depend on specific modifiable environmental conditions, such as intestinal nematode infections which require contamination of the environment by human excreta. These diseases were fully attributed to the environment on the basis of their transmission pathway. When estimates of population impacts from environmental risks were not available or could not be developed in the framework of this study, experts were asked to provide a best estimate of the fraction of the specific disease of the global population attributable to the reasonably modifiable environment, as well as the 95% confidence interval (CI). Experts were selected on the basis of their publications in the area of the disease or the relevant environmental risk factor. They were provided with abstracts of search results of the systematic reviews described earlier, as well as an initial estimate that was based on pooled estimates from the literature. Three or more experts were chosen for each disease or injury. More information on generating PAFs and confidence intervals from the experts' replies is given in Supplementary File (A3). Where the body of evidence resulting from the updated literature review did not substantially differ or was unlikely to justify a change in experts' estimation of PAF, the results of the expert survey of the previous study[1] were taken. To calculate the fraction of disease attributable to a risk factor for any defined population, compiled or estimated PAFs were multiplied by the corresponding WHO disease statistics,[2] by disease or injury, country, sex and age group, and for deaths and DALYs. Equations are listed in Supplementary File (A4).

Compilation of main intervention areas

The evidence on effectiveness of interventions was further compiled by disease in order to summarize the main intervention areas.

Results

Results of environment-attributable deaths and disease burden, the attributable fractions, as well as the respective estimation method are listed in Table 1. The environmental fractions of the burden of selected diseases are shown in Fig. 1. Out of the 133 diseases or injuries, 101 had significant links with the environment, and 92 of them have been at least partially quantified. These 92 were grouped in 66 main disease and injury groups. Of these, global CRAs were available for 20 groups, of which 12 could be exclusively used for those diseases and eight needed to be completed by expert opinion. Eight diseases could be assessed (Table 1) on the basis of more limited epidemiological data, and four further disease PAFs were based on their transmission pathways. The PAFs of the remaining 31 diseases were fully estimated through expert surveys. More than 100 experts provided more than 250 quantitative replies. In terms of estimated environmental disease burden (in DALYs), as much as 56% could be estimated with CRA-type methods (of which 36% with a combination of risk factors), 40% were based on expert surveys (of which 8% in the 2015 round), 3% on estimations using more limited data, and 1% based on transmission pathways (Table 1).
Table 1

Global deaths, disease burden (in DALYs) and fractions attributable to the environment for 2012, and methods used

DiseaseDeaths (in 2012)DALYs (in 2012)Attributable fraction (in DALYs) (95% CI)Estimation method used
Total12 624 495596 412 17122 (13–32)
Infectious and parasitic diseases
Respiratory infections
Lower respiratory infections566 36151 752 60535 (27–41)ae
Upper respiratory infections and otitis1190989 75114 (5–22)d2005
Diarrhoeal diseases845 81056 606 91457 (34–72)af
Intestinal nematode infections
Ascariasis32971 353 195100c
Trichuriasis0664 771100c
Hookworm disease<103 211 578100c
Parasitic and vector diseases
Malaria258 70223 074 44942 (28–55)d2005
Trachoma0298 711100c
Schistosomiasis17 8713 301 30082 (71–92)d2015
Chagas disease4371295 45056 (28–80)d2005
Lymphatic filariasis<101 893 57467 (39–89)d2005
Onchocerciasis059 82710 (7–13)d2005
Leishmaniasis12 952903 05327 (9–40)d2005
Dengue27 2491 369 86795 (89–100)d2005
HIV/AIDS#137 9857 780 32110 (8–13)b
Sexually transmitted diseases excluding HIV/AIDS#8 (4–17)
Syphilis28617 5676 (3–14)b
Chlamydia108115 5678 (3–16)b
Gonorrhoea10563 58812 (7–25)b
Trichomoniasis065994 (2–6)b
Hepatitis B2828111 4462 (1–4)b
Tuberculosis166 6877 688 97118 (5–40)(b), d2005
Other infectious diseases160 41811 463 45027 (17–37)d2005
Neonatal and nutritional conditions
Neonatal conditions270 08725 819 56611 (2–27)d2005
Childhood underweight27 2912 834 18615 (10–19)b
Noncommunicable diseases
Lung cancer568 63213 902 10536 (17–52)ae
Other cancers1 097 14431 047 78116 (7–41)(a), d2005
Mental, behavioural and neurological disorders
Unipolar depressive disorders5368 473 70712 (5–35)d2015
Bipolar disorder30528 9854 (0–9)d2015
Schizophrenia839561 4634 (1–9)d2015
Alcohol use disorders17 1045 121 13216 (6–38)d2015
Drug use disorders10 2131 663 56811 (2–36)d2015
Anxiety disorders135 479 36520 (5–42)d2015
Eating disorders636158 2767 (0–20)d2015
Pervasive developmental disorders546 4437 (0–26)d2015
Childhood behavioural disorders742 15612 (3–36)d2015
Idiopathic intellectual disability106193 7426 (1–25)d2015
Alzheimer‘s disease and other dementias41 9361 088 0366 (1–13)d2015
Parkinson‘s disease8293171 0157 (2–14)d2015
Epilepsy30 0313 023 79215 (2–30)d2015
Multiple sclerosis114169 7296 (1–22)d2015
Migraine<102 585 60814 (2–36)d2015
Non-migraine headache310 61317 (2–46)d2015
Other mental, behavioural and neurological conditions43 2971 985 12111 (2–24)d2015
Sense organ diseases
Cataracts1 669 15724 (14–33)af
Deafness4 787 24222 (19–25)ag
Cardiovascular diseases
Rheumatoid arthritis10 928934 39317 (6–30)ag
Hypertensive heart disease93 6522 146 8309 (5–15)ag
Ischaemic heart disease2 273 81158 561 91535 (26–46)ae
Stroke2 476 55358 985 98442 (24–53)ae
Other circulatory diseases49 2911 355 8223 (1–5)ag
Respiratory diseases
Chronic obstructive pulmonary disease1 193 58932 280 16035 (20–48)ae
Asthma169 44911 055 15044 (26–53)(a), d2005
Chronic kidney diseases27 143759 8263 (1–5)ag
Musculoskeletal diseases
Rheumatoid arthritis6934217–3142 (1–4)d2005
Osteoarthritis8293 606 52920 (11–29)d2005
Back and neck pain15814 627 73327 (17–41)ag, d2015
Other musculoskeletal diseases20 6664 961 74115 (6–24)d2005
Congenital anomalies27 7702 621 8575 (1–10)d2005
Unintentional injuries
Road traffic accidents497 07931 000 88739 (23–64)(a), d2005
Unintentional Poisonings137 3397 824 62773 (53–90)(a), d2005
Falls208 46912 671 69630 (15–58)(a), d2005
Fires199 77613 665 38976 (58–91)(a), (b), d2015
Drownings268 16616 948 33473 (43–94)(a), d2005
Other unintentional injuries393 13623 133 58643 (20–74)(a), d2005
Intentional injuries
Suicide164 3948 119 70021 (13–30)b
Interpersonal violence81 7305 101 92116 (3–28)d2005

HIV/AIDS = human immunodeficiency virus/acquired immunodeficiency syndrome; a: comparative risk assessment type, b: calculation based on limited epidemiological data, c: disease transmission pathway, d2015: expert survey 2015, d2005: expert survey 2005; () Estimates available, but completion by expert survey as main risk-factor disease pair not assessed. e Source: Combination of various risk factors developed for this analysis, WHO, based on references.[9,11–13]f Source: WHO.[10,11]g Source:[13]; see disease-specific sections and Technical Annex of full report for further information.

Fig.1

Environmental fraction of burden of selected diseases (percentages relate to the environmental share of the respective disease).

Global deaths, disease burden (in DALYs) and fractions attributable to the environment for 2012, and methods used HIV/AIDS = human immunodeficiency virus/acquired immunodeficiency syndrome; a: comparative risk assessment type, b: calculation based on limited epidemiological data, c: disease transmission pathway, d2015: expert survey 2015, d2005: expert survey 2005; () Estimates available, but completion by expert survey as main risk-factor disease pair not assessed. e Source: Combination of various risk factors developed for this analysis, WHO, based on references.[9,11-13]f Source: WHO.[10,11]g Source:[13]; see disease-specific sections and Technical Annex of full report for further information. Environmental fraction of burden of selected diseases (percentages relate to the environmental share of the respective disease). A description of the underlying evidence and region-specific results for each disease or injury are detailed in the report along with compiled effectiveness of environmental interventions. Based on a summary of the literature review on interventions, we report a mapping of diseases to main strategies for disease reduction through environmental improvements in Table 2, which are further detailed in the full report.[1]
Table 2

Main areas of strategies for disease reduction through environmental improvements

Disease or Injury[a]Main areas
Infectious and parasitic diseases
Respiratory infectionsHousehold fuel use for cooking, heating and lighting, ambient air pollution, second-hand smoke, housing improvements (to prevent chilling, crowding).
Diarrhoeal diseasesDrinking water quality, improved sanitation facilities, recreational water quality, personal and community hygiene, animal excreta management, agricultural practices, climate change.
Intestinal nematode infectionsSanitation facilities and hygiene to prevent contamination of the environment with excreta, safe management of wastewater for irrigation.
MalariaEnvironmental modification, including drainage, land levelling, filling depressions, pools and ponds, mosquito proof drinking water storage; environmental manipulation, including aquatic vegetation management, safe storage of domestic water, managing peri-domestic waste; reduced contact between humans and disease vectors screening of houses; livestock distribution.
TrachomaAccess to improved sanitation facilities; effective management of human waste; domestic water supplies, fly control, personal hygiene.
SchistosomiasisManagement of human waste, safe drinking water supply, improved irrigation infrastructure and safe irrigation and other agricultural practices; workers’ protection to avoid contact with contaminated water (such as wearing rubber boots).
Chagas diseaseManagement of peri-domestic areas (such as filling cracks in house walls, clearing areas around houses of wood stacks, maintaining goat corrals and chicken dens clean of organic debris).
Lymphatic filariasisModification of drainage and wastewater ponds, freshwater collection and irrigation schemes; impact depends on locally relevant disease vectors.
OnchocerciasisImproved design and operation of water resources development projects (particularly dams).
LeishmaniasisHousing improvements, such as eliminating soil and wall cracks, removal of organic material in the peri-domestic environment, workers’ personal protection.
DengueManagement of water bodies around the house such as removing standing water from open water containers, urban infrastructure improvements, and solid waste management.
Japanese encephalitisIrrigation management in rice-growing areas and distribution of farm animals (mainly pigs), personal protection methods.
HIV/AIDS and sexually transmitted diseasesProgrammes to reduce occupational transmission among sex workers and migrant workers such as construction workers, seasonal agricultural labourers, truck drivers and sailors.
Hepatitis B and COccupational transmission among sex workers and migrant workers for hepatitis B;accidental needle-stick injuries in healthcare workers.
TuberculosisExposure of miners and other occupational groups to airborne particles such as silica or coal dust, possibly exposure to household fuel combustion smoke and second-hand smoke. Managing setting-specific conditions, such as in prisons, hospitals and refugee camps.
Neonatal and nutritional conditions
Neonatal conditionsHousehold air pollution from fuel combustion, mothers’ exposure to environmental tobacco smoke, poor water and sanitation in birth settings.
Childhood underweightProvision of adequate water, sanitation and hygiene, adaptive management addressing climate change acting on food insecurity.
CancersHousehold air pollution from fuel combustion, ambient air pollution, second-hand smoke, ionizing radiation, ultraviolet radiation, exposure to chemicals, exposures at work and in other settings.
Noncommunicable diseases
Neuropsychiatric disordersOccupational stress has been linked to depression and anxiety; posttraumatic stress disorders to disasters such as floods, earthquakes, and fires, which could in part be prevented by environmental measures (e.g., floods by hydraulic infrastructure or land use patterns, or their mitigation of climate change, the impact of earthquakes and fires through more adequate buildings); forced resettlements in the context of development projects; drug use and alcohol disorder to the occupational environment such as working in the entertainment industry; epilepsy to occupational head trauma; Parkinson's disease to exposure to chemicals such as pesticides; intellectual disability to childhood exposure to lead and methylmercury; insomnia to noise and occupational stress; migraine to bright lights, poor air quality and odours. Exercise and physical activity fostered by supportive environments can reduce depression and anxiety.
CataractsProtection from ultraviolet radiation, reduction of household air pollution from combustion smoke.
Hearing lossManaging occupational exposure to high noise levels.
Cardiovascular diseasesReducing or eliminating indoor and outdoor air pollution, second-hand smoke, exposure to lead, stressful working conditions, shift work.
Chronic obstructive pulmonary diseaseReducing or eliminating household air pollution from combustion smoke, ambient air pollution, exposure to dusts in the workplace.
AsthmaReducing or eliminating air pollution, second-hand smoke, exposure to indoor mould and dampness, occupational exposure to allergens.
Musculoskeletal diseasesManaging occupational stressors, such as heavy lifting, vibrations, prolonged sitting and poor work postures; need to carry large quantities of water over significant distances for domestic use.
Congenital anomaliesMothers’ exposure to second-hand smoke, chemicals.
Unintentional injuries
Road traffic accidentsDesign of the roadways (e.g. sidewalks, bicycle lanes, restricted traffic, traffic-calming measures), land-use planning; traffic intensification in development areas with big infrastructure projects.
Unintentional poisoningsSafe handling and storage of chemicals, adequate product information, adequate choice of chemicals, workers’ protection (e.g. protective clothing).
FallsSafety of housing and working environment.
Fires, heat and hot substancesSafety of cooking, lighting and heating equipment, in particular open fires, unsafe stoves or the use of candles or kerosene lamps, building fire codes, use of flammable materials in the home, safety of occupational environments and practices, climate change.
DrowningsSafety of water environments (community infrastructure, physical barriers, prevention and rescue services), public awareness, regulations (e.g. on transportation on waterways), workers’ safety measures, climate change-induced flood risks.
Other unintentional injuriesProtection from animal bites and contact with venomous plants, safety of mechanical equipment (including sports equipment, agricultural and industrial machinery), safety of off-road transportation, protection from exposure to ionizing radiation or electric currents.
Intentional injuries
Self-harmAccess to toxic chemicals such as pesticides, access to firearms.
Interpersonal violenceAccess to firearms, urban design (e.g. mobility, visibility), workers’ protection.
Related risk factors
Physical inactivityWorkplace activity, prolonged sitting at the workplace, travel modes, transport infrastructure and land use patterns (walkability, urban density, land use diversity), availability of suitable parks and open spaces.
ObesityFactors favouring physical activity.

a Disease groups have been aggregated as compared to Table 1, as several disease subgroups have similar reduction strategies.

Main areas of strategies for disease reduction through environmental improvements a Disease groups have been aggregated as compared to Table 1, as several disease subgroups have similar reduction strategies. Environmental risks contributed 23% (95% CI = 13–34%) of the global burden measured in deaths, corresponding to 12.6 million deaths in 2012, and 22% (95% CI = 13–32%) in DALYs. In children under 5 years, as much as 26% of deaths and 25% of DALYs are attributable to the environment. Global deaths attributable to the environment are dominated by 8.2 million deaths from noncommunicable diseases, followed by 2.5 million deaths related to infectious, parasitic, neonatal and nutritional diseases, and 2.0 million deaths from injuries. The difference is much less important in terms of disease burden, with 276, 202 and 118 million DALYs attributable to the environment in noncommunicable diseases; infectious, parasitic, neonatal and nutritional diseases; and injuries, respectively. Whereas there are significantly more deaths from noncommunicable diseases, infectious, parasitic, neonatal and nutritional diseases and injuries affect the young to a greater extent and therefore lead to relatively higher losses of DALYs relative to noncommunicable diseases (Fig. 2).
Fig. 2

Environmental disease burden of overall; infectious, parasitic, neonatal and nutritional nutritional; noncommunicable diseases and injuries by age.

Environmental disease burden of overall; infectious, parasitic, neonatal and nutritional nutritional; noncommunicable diseases and injuries by age. Figure 2 shows that overall disease burden attributable to the environment (thick grey line) peaks for the very young and for adults aged 50–75 years. These two age groups show important susceptibilities to environmental conditions. Children are mainly affected by communicable diseases. For the age group between 50 and 75 years the contributions of infectious diseases and injuries are still significant, while noncommunicable diseases, in particular cardiovascular diseases due to ambient and household air pollution, become very important. Box 1 highlights the shift from environmental disease burden from communicable to noncommunicable diseases between 2002 and 2012. Infectious, parasitic, neonatal and nutritional: PAF from 31% in 2002 to 20% in 2012 Noncommunicable diseases: PAF from 17% in 2002 to 22% in 2012 Injuries: PAF from 37% in 2002 to 38% in 2012 Overall: PAF from 23.3% in 2002 to 22.7% in 2012 Age-standardized deaths and DALYs by country are provided in Tables A1 and A2 of the Supplementary File. While the highest burden of environment-attributable disease is still in Sub-Saharan Africa and dominated by infectious, parasitic, neonatal and nutritional disease burden, the per capita deaths from noncommunicable diseases are now higher in most other regions of the world. Figure 3 shows environmentally related deaths per 100 000 population by gross national income (GNI). The size of the bubbles is proportional to country population. There is a reduction of deaths with increasing income up to a GNI of around 25 000. At larger incomes there is no difference in death rates, with most countries having around 50 deaths per 100 000.
Fig. 3

Environmental burden of disease (deaths per 100 000 population, y-axis) by gross national income per capita (x-axis); each bubble represents a country, bubble size represents population size; BRICS: Brazil, Russia, India, China, South Africa; OECD: Organisation for Economic Co-operation and Development.

Environmental burden of disease (deaths per 100 000 population, y-axis) by gross national income per capita (x-axis); each bubble represents a country, bubble size represents population size; BRICS: Brazil, Russia, India, China, South Africa; OECD: Organisation for Economic Co-operation and Development.

Discussion

What is already known on the topic and what this study adds

Compared to our estimates for 2002, we see a major shift in the importance of environmental factors in noncommunicable disease aetiology. This is due to (i) the composition of the global disease burden which is now dominated by noncommunicable diseases,[14] (ii) increased evidence on environmental determinants of noncommunicable diseases, and (iii) growing importance of environmental factors that contribute to noncommunicable diseases such as air pollution. As the world population continues to age rapidly, the trend of environmental risks predominantly affecting noncommunicable diseases is expected to become more pronounced. One hundred and one out of 133 diseases and injuries were at least partially attributable to manageable environmental factors, as compared to 85 out of 102 in the previous study. In addition, the share of estimates based on the highest evidence level, i.e. using CRA type of approaches, has considerably increased and now reaches 56% (for DALYs), as compared to less than 10% in the previous study. In these high-evidence assessments, exposures are being assessed at country level or higher resolution, such as by age and gender to the extent possible and where appropriate, and the transferability of exposure-risk relationships to other population groups than where assessed are being verified or adjusted. This adds to the comprehensiveness and strength of evidence of the previous report. Nevertheless, our numbers show that environmental factors continue to contribute to a large disease burden from communicable diseases in many low and middle income countries. In these countries, environmental risks leading to infectious diseases especially in children, such as household air pollution, unsafe drinking-water and poor sanitation and personal hygiene are still highly prevalent.[11,15] Furthermore the burden from respiratory and intestinal infections in these countries remains high.[14] At the same time they experience the double burden of communicable and noncommunicable diseases. Our results differ from the Global Burden of Disease Study 2013 (GBD 2013)[8] which attributed 12% of global DALYs and 16% of global mortality to environmental risks, mainly because we used a broader scope of the definition of environment and complementary methods of assessment. Those risks comprise unsafe water, sanitation and hygiene; air pollution (ambient particulate matter, ozone and household air pollution); second-hand smoke; lead and residential radon exposure; and occupational risks[8] (NB: here we do not count burden attributable to physical inactivity/low physical activity as also for our analysis we did not quantify the environmental part of the burden from this risk factor). Our analysis covers a broader range of environmental risks adding noise (only included as occupational noise in GBD 2013); various chemicals; risks associated with poor housing, the recreational environment, water resource management, land use and the built environment; other community risks; radiation and climate change. Additionally, we consider more risk-factor disease links. Furthermore, GBD 2013 rated high blood pressure as most important risk factor, causing alone as much as 19% of global deaths and 8% of all DALYs.[8] Some of this burden can however be attributed to environmental factors such as air pollution,[16,17] arsenic[18] and lead exposure,[19] occupational risks[20] and environmental noise.[21]

Limitations of this study

A large part of this analysis is based on surveys of expert opinion and the uncertainties of such estimates are relatively large. However, experts were provided with the body of evidence that was identified during the systematic searches on the particular disease and its links to the respective environmental risks. We only updated this process when justified by a significant change in evidence. Further uncertainties relate to data limitations and assumptions made in e.g. CRA type of analyses.[8,11-13] Also key exposures at younger ages, which may result in noncommunicable diseases at older ages could not be adequately captured in this study. Certain diseases or environmental risk factors were not included in our analysis, either because there was insufficient evidence and therefore health effects were not quantifiable (e.g. changed, damaged or depleted ecosystems and exposure to endocrine disrupting substances), or because the risk factor(s) caused a relatively small disease burden, or is/are of regional significance but do not feature at a global scale. Environmental risks not readily modifiable, e.g. pollen, were not considered. Additional conservative approaches have been chosen for this analysis as compared to the previous one in order to increase methodological rigour. For example, (a) only the main environmental risks were quantified where CRA estimates were available, and (b) the exposures of similar risks were combined before the estimation of health impacts. The environmental disease burden measured in DALYs between 2002 and 2012 is not directly comparable as some of the basic parameters as discounting and age-weighting for DALY estimation changed during this period.[22] Using the same methods, the change would have been greater, as more deaths are now due to noncommunicable diseases, which tend to occur at older ages, and induce fewer years of life lost (and fewer DALYs). We have not considered health impacts of social determinants.[23] There is, however, a strong link between the conditions of people's daily lives and environmental risks to health. The lower people's socioeconomic status the more likely they are to be exposed to environmental risks, such as chemicals, air pollution and poor housing, water, sanitation and hygiene. Poor people and communities are therefore likely to benefit most from environmental interventions as they are disproportionally affected by adverse environments.[24]

Policy implications

In principle, and given the methods and definitions chosen, the attributable burden here equates what can be prevented if the risks were removed. While we currently have solutions for reducing many of the prevailing risks, interventions that are affordable and that could completely eliminate certain risks such as ambient air pollution at a larger scale may require further development. Others, such as use of solid fuels, could be removed with almost immediate effect if the necessary means were made available. Yet for exposures which seem unavoidable in the short term, approaches are being considered which would require certain transformations in the way we currently produce and consume. Important calls for action are coming from two main global platforms. One of them was created by the adoption of the SDGs in September 2015.[25] It was significant that the Heads of State gathered at a Special Session of the UN General Assembly did not agree on another agenda or declaration, but made a pledge to ‘the transformation of our earth’. Full adherence to the obligations created by this pledge, even if only moral could result in important improvements on the reduction of environmental risks. The Supplementary File (A5, Table A3) gives further information on SDGs and their links with a healthy environment. The other is climate change. International efforts to reduce our carbon footprint (one such example is the recent Paris Agreement, the first global agreement to reduce climate change[26]) would lead to innovative interventions with positive ramifications to several key environmental factors, including to air pollution, water, chemicals, among others.

Conclusions

This analysis, which confirms that reducing environmental exposures can greatly improve our health and is critical for attaining the SDGs, has been generated considering a large list of environmental risk factors and risk factor-disease links. For half of those links, CRA types of assessment were available basing the results on solid evidence. In conclusion, our results convey good news as we included only those environmental exposures that are amenable to change, meaning that interventions exist for removing a large part of global disease burden. A prerequisite would be a stronger focus on primary prevention placing a healthy environment at the centre of such an effort. This is not a task for ministries of health alone. Tackling environmental risks requires intersectoral collaboration. After nearly 50 years of actively promoting this concept, whether referred to as intersectoral action, breaking down silos or the nexus approach, it remains elusive as ever. The statement ‘intersectoral collaboration: loved by all, funded by no-one’ points to obstacles, mainly vested interests, that have burdened this approach ever since it was included as part of the WHO/UNICEF Alma Ata Declaration on Primary Health Care in 1978. Environmental health, quintessentially intersectoral, has suffered most from this lack of progress. There remain a number of health sector-specific functions (monitoring, surveillance), but for the actual interventions the health sector will have to create the enabling environment for intersectoral action. Investing in environmental interventions pays off for governments; it reduces the transfer of hidden costs from other sectors to the health sector. This new report provides the evidence base for intersectoral action providing the evidence to systematically consider the integration of measures into all policy areas. Click here for additional data file.
  13 in total

Review 1.  Is hypertension associated with job strain? A meta-analysis of observational studies.

Authors:  Giridhara R Babu; A T Jotheeswaran; Tanmay Mahapatra; Sanchita Mahapatra; Ananth Kumar; Roger Detels; Neil Pearce
Journal:  Occup Environ Med       Date:  2013-09-24       Impact factor: 4.402

2.  Bone lead levels and blood pressure endpoints: a meta-analysis.

Authors:  Ana Navas-Acien; Brian S Schwartz; Stephen J Rothenberg; Howard Hu; Ellen K Silbergeld; Eliseo Guallar
Journal:  Epidemiology       Date:  2008-05       Impact factor: 4.822

3.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

Review 4.  Arsenic exposure and hypertension: a systematic review.

Authors:  Lalita N Abhyankar; Miranda R Jones; Eliseo Guallar; Ana Navas-Acien
Journal:  Environ Health Perspect       Date:  2011-12-02       Impact factor: 9.031

5.  Indoor air pollution and blood pressure in adult women living in rural China.

Authors:  Jill Baumgartner; James J Schauer; Majid Ezzati; Lin Lu; Chun Cheng; Jonathan A Patz; Leonelo E Bautista
Journal:  Environ Health Perspect       Date:  2011-07-01       Impact factor: 9.031

6.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors:  Mohammad H Forouzanfar; Lily Alexander; H Ross Anderson; Victoria F Bachman; Stan Biryukov; Michael Brauer; Richard Burnett; Daniel Casey; Matthew M Coates; Aaron Cohen; Kristen Delwiche; Kara Estep; Joseph J Frostad; K C Astha; Hmwe H Kyu; Maziar Moradi-Lakeh; Marie Ng; Erica Leigh Slepak; Bernadette A Thomas; Joseph Wagner; Gunn Marit Aasvang; Cristiana Abbafati; Ayse Abbasoglu Ozgoren; Foad Abd-Allah; Semaw F Abera; Victor Aboyans; Biju Abraham; Jerry Puthenpurakal Abraham; Ibrahim Abubakar; Niveen M E Abu-Rmeileh; Tania C Aburto; Tom Achoki; Ademola Adelekan; Koranteng Adofo; Arsène K Adou; José C Adsuar; Ashkan Afshin; Emilie E Agardh; Mazin J Al Khabouri; Faris H Al Lami; Sayed Saidul Alam; Deena Alasfoor; Mohammed I Albittar; Miguel A Alegretti; Alicia V Aleman; Zewdie A Alemu; Rafael Alfonso-Cristancho; Samia Alhabib; Raghib Ali; Mohammed K Ali; François Alla; Peter Allebeck; Peter J Allen; Ubai Alsharif; Elena Alvarez; Nelson Alvis-Guzman; Adansi A Amankwaa; Azmeraw T Amare; Emmanuel A Ameh; Omid Ameli; Heresh Amini; Walid Ammar; Benjamin O Anderson; Carl Abelardo T Antonio; Palwasha Anwari; Solveig Argeseanu Cunningham; Johan Arnlöv; Valentina S Arsic Arsenijevic; Al Artaman; Rana J Asghar; Reza Assadi; Lydia S Atkins; Charles Atkinson; Marco A Avila; Baffour Awuah; Alaa Badawi; Maria C Bahit; Talal Bakfalouni; Kalpana Balakrishnan; Shivanthi Balalla; Ravi Kumar Balu; Amitava Banerjee; Ryan M Barber; Suzanne L Barker-Collo; Simon Barquera; Lars Barregard; Lope H Barrero; Tonatiuh Barrientos-Gutierrez; Ana C Basto-Abreu; Arindam Basu; Sanjay Basu; Mohammed O Basulaiman; Carolina Batis Ruvalcaba; Justin Beardsley; Neeraj Bedi; Tolesa Bekele; Michelle L Bell; Corina Benjet; Derrick A Bennett; Habib Benzian; Eduardo Bernabé; Tariku J Beyene; Neeraj Bhala; Ashish Bhalla; Zulfiqar A Bhutta; Boris Bikbov; Aref A Bin Abdulhak; Jed D Blore; Fiona M Blyth; Megan A Bohensky; Berrak Bora Başara; Guilherme Borges; Natan M Bornstein; Dipan Bose; Soufiane Boufous; Rupert R Bourne; Michael Brainin; Alexandra Brazinova; Nicholas J Breitborde; Hermann Brenner; Adam D M Briggs; David M Broday; Peter M Brooks; Nigel G Bruce; Traolach S Brugha; Bert Brunekreef; Rachelle Buchbinder; Linh N Bui; Gene Bukhman; Andrew G Bulloch; Michael Burch; Peter G J Burney; Ismael R Campos-Nonato; Julio C Campuzano; Alejandra J Cantoral; Jack Caravanos; Rosario Cárdenas; Elisabeth Cardis; David O Carpenter; Valeria Caso; Carlos A Castañeda-Orjuela; Ruben E Castro; Ferrán Catalá-López; Fiorella Cavalleri; Alanur Çavlin; Vineet K Chadha; Jung-Chen Chang; Fiona J Charlson; Honglei Chen; Wanqing Chen; Zhengming Chen; Peggy P Chiang; Odgerel Chimed-Ochir; Rajiv Chowdhury; Costas A Christophi; Ting-Wu Chuang; Sumeet S Chugh; Massimo Cirillo; Thomas K D Claßen; Valentina Colistro; Mercedes Colomar; Samantha M Colquhoun; Alejandra G Contreras; Cyrus Cooper; Kimberly Cooperrider; Leslie T Cooper; Josef Coresh; Karen J Courville; Michael H Criqui; Lucia Cuevas-Nasu; James Damsere-Derry; Hadi Danawi; Lalit Dandona; Rakhi Dandona; Paul I Dargan; Adrian Davis; Dragos V Davitoiu; Anand Dayama; E Filipa de Castro; Vanessa De la Cruz-Góngora; Diego De Leo; Graça de Lima; Louisa Degenhardt; Borja del Pozo-Cruz; Robert P Dellavalle; Kebede Deribe; Sarah Derrett; Don C Des Jarlais; Muluken Dessalegn; Gabrielle A deVeber; Karen M Devries; Samath D Dharmaratne; Mukesh K Dherani; Daniel Dicker; Eric L Ding; Klara Dokova; E Ray Dorsey; Tim R Driscoll; Leilei Duan; Adnan M Durrani; Beth E Ebel; Richard G Ellenbogen; Yousef M Elshrek; Matthias Endres; Sergey P Ermakov; Holly E Erskine; Babak Eshrati; Alireza Esteghamati; Saman Fahimi; Emerito Jose A Faraon; Farshad Farzadfar; Derek F J Fay; Valery L Feigin; Andrea B Feigl; Seyed-Mohammad Fereshtehnejad; Alize J Ferrari; Cleusa P Ferri; Abraham D Flaxman; Thomas D Fleming; Nataliya Foigt; Kyle J Foreman; Urbano Fra Paleo; Richard C Franklin; Belinda Gabbe; Lynne Gaffikin; Emmanuela Gakidou; Amiran Gamkrelidze; Fortuné G Gankpé; Ron T Gansevoort; Francisco A García-Guerra; Evariste Gasana; Johanna M Geleijnse; Bradford D Gessner; Pete Gething; Katherine B Gibney; Richard F Gillum; Ibrahim A M Ginawi; Maurice Giroud; Giorgia Giussani; Shifalika Goenka; Ketevan Goginashvili; Hector Gomez Dantes; Philimon Gona; Teresita Gonzalez de Cosio; Dinorah González-Castell; Carolyn C Gotay; Atsushi Goto; Hebe N Gouda; Richard L Guerrant; Harish C Gugnani; Francis Guillemin; David Gunnell; Rahul Gupta; Rajeev Gupta; Reyna A Gutiérrez; Nima Hafezi-Nejad; Holly Hagan; Maria Hagstromer; Yara A Halasa; Randah R Hamadeh; Mouhanad Hammami; Graeme J Hankey; Yuantao Hao; Hilda L Harb; Tilahun Nigatu Haregu; Josep Maria Haro; Rasmus Havmoeller; Simon I Hay; Mohammad T Hedayati; Ileana B Heredia-Pi; Lucia Hernandez; Kyle R Heuton; Pouria Heydarpour; Martha Hijar; Hans W Hoek; Howard J Hoffman; John C Hornberger; H Dean Hosgood; Damian G Hoy; Mohamed Hsairi; Guoqing Hu; Howard Hu; Cheng Huang; John J Huang; Bryan J Hubbell; Laetitia Huiart; Abdullatif Husseini; Marissa L Iannarone; Kim M Iburg; Bulat T Idrisov; Nayu Ikeda; Kaire Innos; Manami Inoue; Farhad Islami; Samaya Ismayilova; Kathryn H Jacobsen; Henrica A Jansen; Deborah L Jarvis; Simerjot K Jassal; Alejandra Jauregui; Sudha Jayaraman; Panniyammakal Jeemon; Paul N Jensen; Vivekanand Jha; Fan Jiang; Guohong Jiang; Ying Jiang; Jost B Jonas; Knud Juel; Haidong Kan; Sidibe S Kany Roseline; Nadim E Karam; André Karch; Corine K Karema; Ganesan Karthikeyan; Anil Kaul; Norito Kawakami; Dhruv S Kazi; Andrew H Kemp; Andre P Kengne; Andre Keren; Yousef S Khader; Shams Eldin Ali Hassan Khalifa; Ejaz A Khan; Young-Ho Khang; Shahab Khatibzadeh; Irma Khonelidze; Christian Kieling; Daniel Kim; Sungroul Kim; Yunjin Kim; Ruth W Kimokoti; Yohannes Kinfu; Jonas M Kinge; Brett M Kissela; Miia Kivipelto; Luke D Knibbs; Ann Kristin Knudsen; Yoshihiro Kokubo; M Rifat Kose; Soewarta Kosen; Alexander Kraemer; Michael Kravchenko; Sanjay Krishnaswami; Hans Kromhout; Tiffany Ku; Barthelemy Kuate Defo; Burcu Kucuk Bicer; Ernst J Kuipers; Chanda Kulkarni; Veena S Kulkarni; G Anil Kumar; Gene F Kwan; Taavi Lai; Arjun Lakshmana Balaji; Ratilal Lalloo; Tea Lallukka; Hilton Lam; Qing Lan; Van C Lansingh; Heidi J Larson; Anders Larsson; Dennis O Laryea; Pablo M Lavados; Alicia E Lawrynowicz; Janet L Leasher; Jong-Tae Lee; James Leigh; Ricky Leung; Miriam Levi; Yichong Li; Yongmei Li; Juan Liang; Xiaofeng Liang; Stephen S Lim; M Patrice Lindsay; Steven E Lipshultz; Shiwei Liu; Yang Liu; Belinda K Lloyd; Giancarlo Logroscino; Stephanie J London; Nancy Lopez; Joannie Lortet-Tieulent; Paulo A Lotufo; Rafael Lozano; Raimundas Lunevicius; Jixiang Ma; Stefan Ma; Vasco M P Machado; Michael F MacIntyre; Carlos Magis-Rodriguez; Abbas A Mahdi; Marek Majdan; Reza Malekzadeh; Srikanth Mangalam; Christopher C Mapoma; Marape Marape; Wagner Marcenes; David J Margolis; Christopher Margono; Guy B Marks; Randall V Martin; Melvin B Marzan; Mohammad T Mashal; Felix Masiye; Amanda J Mason-Jones; Kunihiro Matsushita; Richard Matzopoulos; Bongani M Mayosi; Tasara T Mazorodze; Abigail C McKay; Martin McKee; Abigail McLain; Peter A Meaney; Catalina Medina; Man Mohan Mehndiratta; Fabiola Mejia-Rodriguez; Wubegzier Mekonnen; Yohannes A Melaku; Michele Meltzer; Ziad A Memish; Walter Mendoza; George A Mensah; Atte Meretoja; Francis Apolinary Mhimbira; Renata Micha; Ted R Miller; Edward J Mills; Awoke Misganaw; Santosh Mishra; Norlinah Mohamed Ibrahim; Karzan A Mohammad; Ali H Mokdad; Glen L Mola; Lorenzo Monasta; Julio C Montañez Hernandez; Marcella Montico; Ami R Moore; Lidia Morawska; Rintaro Mori; Joanna Moschandreas; Wilkister N Moturi; Dariush Mozaffarian; Ulrich O Mueller; Mitsuru Mukaigawara; Erin C Mullany; Kinnari S Murthy; Mohsen Naghavi; Ziad Nahas; Aliya Naheed; Kovin S Naidoo; Luigi Naldi; Devina Nand; Vinay Nangia; K M Venkat Narayan; Denis Nash; Bruce Neal; Chakib Nejjari; Sudan P Neupane; Charles R Newton; Frida N Ngalesoni; Jean de Dieu Ngirabega; Grant Nguyen; Nhung T Nguyen; Mark J Nieuwenhuijsen; Muhammad I Nisar; José R Nogueira; Joan M Nolla; Sandra Nolte; Ole F Norheim; Rosana E Norman; Bo Norrving; Luke Nyakarahuka; In-Hwan Oh; Takayoshi Ohkubo; Bolajoko O Olusanya; Saad B Omer; John Nelson Opio; Ricardo Orozco; Rodolfo S Pagcatipunan; Amanda W Pain; Jeyaraj D Pandian; Carlo Irwin A Panelo; Christina Papachristou; Eun-Kee Park; Charles D Parry; Angel J Paternina Caicedo; Scott B Patten; Vinod K Paul; Boris I Pavlin; Neil Pearce; Lilia S Pedraza; Andrea Pedroza; Ljiljana Pejin Stokic; Ayfer Pekericli; David M Pereira; Rogelio Perez-Padilla; Fernando Perez-Ruiz; Norberto Perico; Samuel A L Perry; Aslam Pervaiz; Konrad Pesudovs; Carrie B Peterson; Max Petzold; Michael R Phillips; Hwee Pin Phua; Dietrich Plass; Dan Poenaru; Guilherme V Polanczyk; Suzanne Polinder; Constance D Pond; C Arden Pope; Daniel Pope; Svetlana Popova; Farshad Pourmalek; John Powles; Dorairaj Prabhakaran; Noela M Prasad; Dima M Qato; Amado D Quezada; D Alex A Quistberg; Lionel Racapé; Anwar Rafay; Kazem Rahimi; Vafa Rahimi-Movaghar; Sajjad Ur Rahman; Murugesan Raju; Ivo Rakovac; Saleem M Rana; Mayuree Rao; Homie Razavi; K Srinath Reddy; Amany H Refaat; Jürgen Rehm; Giuseppe Remuzzi; Antonio L Ribeiro; Patricia M Riccio; Lee Richardson; Anne Riederer; Margaret Robinson; Anna Roca; Alina Rodriguez; David Rojas-Rueda; Isabelle Romieu; Luca Ronfani; Robin Room; Nobhojit Roy; George M Ruhago; Lesley Rushton; Nsanzimana Sabin; Ralph L Sacco; Sukanta Saha; Ramesh Sahathevan; Mohammad Ali Sahraian; Joshua A Salomon; Deborah Salvo; Uchechukwu K Sampson; Juan R Sanabria; Luz Maria Sanchez; Tania G Sánchez-Pimienta; Lidia Sanchez-Riera; Logan Sandar; Itamar S Santos; Amir Sapkota; Maheswar Satpathy; James E Saunders; Monika Sawhney; Mete I Saylan; Peter Scarborough; Jürgen C Schmidt; Ione J C Schneider; Ben Schöttker; David C Schwebel; James G Scott; Soraya Seedat; Sadaf G Sepanlou; Berrin Serdar; Edson E Servan-Mori; Gavin Shaddick; Saeid Shahraz; Teresa Shamah Levy; Siyi Shangguan; Jun She; Sara Sheikhbahaei; Kenji Shibuya; Hwashin H Shin; Yukito Shinohara; Rahman Shiri; Kawkab Shishani; Ivy Shiue; Inga D Sigfusdottir; Donald H Silberberg; Edgar P Simard; Shireen Sindi; Abhishek Singh; Gitanjali M Singh; Jasvinder A Singh; Vegard Skirbekk; Karen Sliwa; Michael Soljak; Samir Soneji; Kjetil Søreide; Sergey Soshnikov; Luciano A Sposato; Chandrashekhar T Sreeramareddy; Nicolas J C Stapelberg; Vasiliki Stathopoulou; Nadine Steckling; Dan J Stein; Murray B Stein; Natalie Stephens; Heidi Stöckl; Kurt Straif; Konstantinos Stroumpoulis; Lela Sturua; Bruno F Sunguya; Soumya Swaminathan; Mamta Swaroop; Bryan L Sykes; Karen M Tabb; Ken Takahashi; Roberto T Talongwa; Nikhil Tandon; David Tanne; Marcel Tanner; Mohammad Tavakkoli; Braden J Te Ao; Carolina M Teixeira; Martha M Téllez Rojo; Abdullah S Terkawi; José Luis Texcalac-Sangrador; Sarah V Thackway; Blake Thomson; Andrew L Thorne-Lyman; Amanda G Thrift; George D Thurston; Taavi Tillmann; Myriam Tobollik; Marcello Tonelli; Fotis Topouzis; Jeffrey A Towbin; Hideaki Toyoshima; Jefferson Traebert; Bach X Tran; Leonardo Trasande; Matias Trillini; Ulises Trujillo; Zacharie Tsala Dimbuene; Miltiadis Tsilimbaris; Emin Murat Tuzcu; Uche S Uchendu; Kingsley N Ukwaja; Selen B Uzun; Steven van de Vijver; Rita Van Dingenen; Coen H van Gool; Jim van Os; Yuri Y Varakin; Tommi J Vasankari; Ana Maria N Vasconcelos; Monica S Vavilala; Lennert J Veerman; Gustavo Velasquez-Melendez; N Venketasubramanian; Lakshmi Vijayakumar; Salvador Villalpando; Francesco S Violante; Vasiliy Victorovich Vlassov; Stein Emil Vollset; Gregory R Wagner; Stephen G Waller; Mitchell T Wallin; Xia Wan; Haidong Wang; JianLi Wang; Linhong Wang; Wenzhi Wang; Yanping Wang; Tati S Warouw; Charlotte H Watts; Scott Weichenthal; Elisabete Weiderpass; Robert G Weintraub; Andrea Werdecker; K Ryan Wessells; Ronny Westerman; Harvey A Whiteford; James D Wilkinson; Hywel C Williams; Thomas N Williams; Solomon M Woldeyohannes; Charles D A Wolfe; John Q Wong; Anthony D Woolf; Jonathan L Wright; Brittany Wurtz; Gelin Xu; Lijing L Yan; Gonghuan Yang; Yuichiro Yano; Pengpeng Ye; Muluken Yenesew; Gökalp K Yentür; Paul Yip; Naohiro Yonemoto; Seok-Jun Yoon; Mustafa Z Younis; Zourkaleini Younoussi; Chuanhua Yu; Maysaa E Zaki; Yong Zhao; Yingfeng Zheng; Maigeng Zhou; Jun Zhu; Shankuan Zhu; Xiaonong Zou; Joseph R Zunt; Alan D Lopez; Theo Vos; Christopher J Murray
Journal:  Lancet       Date:  2015-09-11       Impact factor: 79.321

7.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Christopher J L Murray; Theo Vos; Rafael Lozano; Mohsen Naghavi; Abraham D Flaxman; Catherine Michaud; Majid Ezzati; Kenji Shibuya; Joshua A Salomon; Safa Abdalla; Victor Aboyans; Jerry Abraham; Ilana Ackerman; Rakesh Aggarwal; Stephanie Y Ahn; Mohammed K Ali; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Adil N Bahalim; Suzanne Barker-Collo; Lope H Barrero; David H Bartels; Maria-Gloria Basáñez; Amanda Baxter; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Eduardo Bernabé; Kavi Bhalla; Bishal Bhandari; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; James A Black; Hannah Blencowe; Jed D Blore; Fiona Blyth; Ian Bolliger; Audrey Bonaventure; Soufiane Boufous; Rupert Bourne; Michel Boussinesq; Tasanee Braithwaite; Carol Brayne; Lisa Bridgett; Simon Brooker; Peter Brooks; Traolach S Brugha; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Geoffrey Buckle; Christine M Budke; Michael Burch; Peter Burney; Roy Burstein; Bianca Calabria; Benjamin Campbell; Charles E Canter; Hélène Carabin; Jonathan Carapetis; Loreto Carmona; Claudia Cella; Fiona Charlson; Honglei Chen; Andrew Tai-Ann Cheng; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Manu Dahiya; Nabila Dahodwala; James Damsere-Derry; Goodarz Danaei; Adrian Davis; Diego De Leo; Louisa Degenhardt; Robert Dellavalle; Allyne Delossantos; Julie Denenberg; Sarah Derrett; Don C Des Jarlais; Samath D Dharmaratne; Mukesh Dherani; Cesar Diaz-Torne; Helen Dolk; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Karen Edmond; Alexis Elbaz; Suad Eltahir Ali; Holly Erskine; Patricia J Erwin; Patricia Espindola; Stalin E Ewoigbokhan; Farshad Farzadfar; Valery Feigin; David T Felson; Alize Ferrari; Cleusa P Ferri; Eric M Fèvre; Mariel M Finucane; Seth Flaxman; Louise Flood; Kyle Foreman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Marlene Fransen; Michael K Freeman; Belinda J Gabbe; Sherine E Gabriel; Emmanuela Gakidou; Hammad A Ganatra; Bianca Garcia; Flavio Gaspari; Richard F Gillum; Gerhard Gmel; Diego Gonzalez-Medina; Richard Gosselin; Rebecca Grainger; Bridget Grant; Justina Groeger; Francis Guillemin; David Gunnell; Ramyani Gupta; Juanita Haagsma; Holly Hagan; Yara A Halasa; Wayne Hall; Diana Haring; Josep Maria Haro; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Hideki Higashi; Catherine Hill; Bruno Hoen; Howard Hoffman; Peter J Hotez; Damian Hoy; John J Huang; Sydney E Ibeanusi; Kathryn H Jacobsen; Spencer L James; Deborah Jarvis; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Jost B Jonas; Ganesan Karthikeyan; Nicholas Kassebaum; Norito Kawakami; Andre Keren; Jon-Paul Khoo; Charles H King; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Francine Laden; Ratilal Lalloo; Laura L Laslett; Tim Lathlean; Janet L Leasher; Yong Yi Lee; James Leigh; Daphna Levinson; Stephen S Lim; Elizabeth Limb; John Kent Lin; Michael Lipnick; Steven E Lipshultz; Wei Liu; Maria Loane; Summer Lockett Ohno; Ronan Lyons; Jacqueline Mabweijano; Michael F MacIntyre; Reza Malekzadeh; Leslie Mallinger; Sivabalan Manivannan; Wagner Marcenes; Lyn March; David J Margolis; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; Neil McGill; John McGrath; Maria Elena Medina-Mora; Michele Meltzer; George A Mensah; Tony R Merriman; Ana-Claire Meyer; Valeria Miglioli; Matthew Miller; Ted R Miller; Philip B Mitchell; Charles Mock; Ana Olga Mocumbi; Terrie E Moffitt; Ali A Mokdad; Lorenzo Monasta; Marcella Montico; Maziar Moradi-Lakeh; Andrew Moran; Lidia Morawska; Rintaro Mori; Michele E Murdoch; Michael K Mwaniki; Kovin Naidoo; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Paul K Nelson; Robert G Nelson; Michael C Nevitt; Charles R Newton; Sandra Nolte; Paul Norman; Rosana Norman; Martin O'Donnell; Simon O'Hanlon; Casey Olives; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Andrew Page; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Scott B Patten; Neil Pearce; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; Konrad Pesudovs; David Phillips; Michael R Phillips; Kelsey Pierce; Sébastien Pion; Guilherme V Polanczyk; Suzanne Polinder; C Arden Pope; Svetlana Popova; Esteban Porrini; Farshad Pourmalek; Martin Prince; Rachel L Pullan; Kapa D Ramaiah; Dharani Ranganathan; Homie Razavi; Mathilda Regan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Kathryn Richardson; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Felipe Rodriguez De Leòn; Luca Ronfani; Robin Room; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Sukanta Saha; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; David C Schwebel; James Graham Scott; Maria Segui-Gomez; Saeid Shahraz; Donald S Shepard; Hwashin Shin; Rupak Shivakoti; David Singh; Gitanjali M Singh; Jasvinder A Singh; Jessica Singleton; David A Sleet; Karen Sliwa; Emma Smith; Jennifer L Smith; Nicolas J C Stapelberg; Andrew Steer; Timothy Steiner; Wilma A Stolk; Lars Jacob Stovner; Christopher Sudfeld; Sana Syed; Giorgio Tamburlini; Mohammad Tavakkoli; Hugh R Taylor; Jennifer A Taylor; William J Taylor; Bernadette Thomas; W Murray Thomson; George D Thurston; Imad M Tleyjeh; Marcello Tonelli; Jeffrey A Towbin; Thomas Truelsen; Miltiadis K Tsilimbaris; Clotilde Ubeda; Eduardo A Undurraga; Marieke J van der Werf; Jim van Os; Monica S Vavilala; N Venketasubramanian; Mengru Wang; Wenzhi Wang; Kerrianne Watt; David J Weatherall; Martin A Weinstock; Robert Weintraub; Marc G Weisskopf; Myrna M Weissman; Richard A White; Harvey Whiteford; Natasha Wiebe; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Sean R M Williams; Emma Witt; Frederick Wolfe; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Anita K M Zaidi; Zhi-Jie Zheng; David Zonies; Alan D Lopez; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

8.  Solid fuel use for household cooking: country and regional estimates for 1980-2010.

Authors:  Sophie Bonjour; Heather Adair-Rohani; Jennyfer Wolf; Nigel G Bruce; Sumi Mehta; Annette Prüss-Ustün; Maureen Lahiff; Eva A Rehfuess; Vinod Mishra; Kirk R Smith
Journal:  Environ Health Perspect       Date:  2013-05-03       Impact factor: 9.031

9.  Arterial blood pressure and long-term exposure to traffic-related air pollution: an analysis in the European Study of Cohorts for Air Pollution Effects (ESCAPE).

Authors:  Kateryna B Fuks; Gudrun Weinmayr; Maria Foraster; Julia Dratva; Regina Hampel; Danny Houthuijs; Bente Oftedal; Anna Oudin; Sviatlana Panasevich; Johanna Penell; Johan N Sommar; Mette Sørensen; Pekka Tiittanen; Kathrin Wolf; Wei W Xun; Inmaculada Aguilera; Xavier Basagaña; Rob Beelen; Michiel L Bots; Bert Brunekreef; H Bas Bueno-de-Mesquita; Barbara Caracciolo; Marta Cirach; Ulf de Faire; Audrey de Nazelle; Marloes Eeftens; Roberto Elosua; Raimund Erbel; Bertil Forsberg; Laura Fratiglioni; Jean-Michel Gaspoz; Agneta Hilding; Antti Jula; Michal Korek; Ursula Krämer; Nino Künzli; Timo Lanki; Karin Leander; Patrik K E Magnusson; Jaume Marrugat; Mark J Nieuwenhuijsen; Claes-Göran Ostenson; Nancy L Pedersen; Göran Pershagen; Harish C Phuleria; Nicole M Probst-Hensch; Ole Raaschou-Nielsen; Emmanuel Schaffner; Tamara Schikowski; Christian Schindler; Per E Schwarze; Anne J Søgaard; Dorothea Sugiri; Wim J R Swart; Ming-Yi Tsai; Anu W Turunen; Paolo Vineis; Annette Peters; Barbara Hoffmann
Journal:  Environ Health Perspect       Date:  2014-05-16       Impact factor: 9.031

10.  Burden of disease from inadequate water, sanitation and hygiene in low- and middle-income settings: a retrospective analysis of data from 145 countries.

Authors:  Annette Prüss-Ustün; Jamie Bartram; Thomas Clasen; John M Colford; Oliver Cumming; Valerie Curtis; Sophie Bonjour; Alan D Dangour; Jennifer De France; Lorna Fewtrell; Matthew C Freeman; Bruce Gordon; Paul R Hunter; Richard B Johnston; Colin Mathers; Daniel Mäusezahl; Kate Medlicott; Maria Neira; Meredith Stocks; Jennyfer Wolf; Sandy Cairncross
Journal:  Trop Med Int Health       Date:  2014-04-30       Impact factor: 2.622

View more
  40 in total

1.  Building Healthy Community Environments: A Public Health Approach.

Authors:  Kirsten Koehler; Megan Latshaw; Thomas Matte; Daniel Kass; Howard Frumkin; Mary Fox; Benjamin F Hobbs; Marsha Wills-Karp; Thomas A Burke
Journal:  Public Health Rep       Date:  2018 Nov/Dec       Impact factor: 2.792

2.  Environmental sensitivity as a trigger of erythema nodosum and perimenopausal symptoms.

Authors:  Randy Horwitz; Victoria Maizes
Journal:  BMJ Case Rep       Date:  2017-08-01

3.  Long-term effects of air pollution: an exposome meet-in-the-middle approach.

Authors:  Paolo Vineis; Christiana A Demetriou; Nicole Probst-Hensch
Journal:  Int J Public Health       Date:  2020-01-11       Impact factor: 3.380

4.  Cardiotoxicity Hazard and Risk Characterization of ToxCast Chemicals Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes from Multiple Donors.

Authors:  Sarah D Burnett; Alexander D Blanchette; Weihsueh A Chiu; Ivan Rusyn
Journal:  Chem Res Toxicol       Date:  2021-08-27       Impact factor: 3.739

Review 5.  Hydrogels and Hydrogel Nanocomposites: Enhancing Healthcare through Human and Environmental Treatment.

Authors:  Angela M Gutierrez; Erin Molly Frazar; Maria Victoria X Klaus; Pranto Paul; J Zach Hilt
Journal:  Adv Healthc Mater       Date:  2021-12-11       Impact factor: 9.933

6.  Effectiveness of a home-environmental intervention package and an early child development intervention on child health and development in high-altitude rural communities in the Peruvian Andes: a cluster-randomised controlled trial.

Authors:  Néstor Nuño; Daniel Mäusezahl; Jan Hattendorf; Hector Verastegui; Mariela Ortiz; Stella M Hartinger
Journal:  Infect Dis Poverty       Date:  2022-06-06       Impact factor: 10.485

7.  "Knocking on Doors that Don't Open": experiences of caregivers of children living with disabilities in Iquitos and Lima, Peru.

Authors:  Ines M Aguerre; Amy R Riley-Powell; Caroline T Weldon; Monica J Pajuelo; Rosa A Celis Nacimento; Anité Puente-Arnao; Lilia Cabrera; Richard A Oberhelman; Valerie A Paz-Soldan
Journal:  Disabil Rehabil       Date:  2018-06-17       Impact factor: 3.033

Review 8.  Application of metabolomics to characterize environmental pollutant toxicity and disease risks.

Authors:  Pan Deng; Xusheng Li; Michael C Petriello; Chunyan Wang; Andrew J Morris; Bernhard Hennig
Journal:  Rev Environ Health       Date:  2019-09-25       Impact factor: 4.022

Review 9.  Detecting and Attributing Health Burdens to Climate Change.

Authors:  Kristie L Ebi; Nicholas H Ogden; Jan C Semenza; Alistair Woodward
Journal:  Environ Health Perspect       Date:  2017-08-07       Impact factor: 9.031

10.  Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk characterization.

Authors:  Sarah D Burnett; Alexander D Blanchette; Weihsueh A Chiu; Ivan Rusyn
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-03-08       Impact factor: 4.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.